MK-2866 Ostarine Powder Details
Product Name: Ostarine powder (mk2866 powder mk-2866 powder enobosarm)
Molecular Weight: 389.3279696
Boiling Point: °C at 760 mmHg
Package: be packed according to the customer requirements and packaging specifications.
Appearance: White crystalline powder
MK-2866 Ostarine Powder Dosage
A dose of 25mg per day of (MK-2866) is recommended for males and 12.5mg per day for females. Each bottle has 30ml with an average dose being 1ml for males or .5ml for females. 1ml is 3/4 of the dropper or 25mg. Each bottle contains 30+ days of use. Cycle Length 6 – 8 weeks.
A dose of 25mg per day of (MK-677) is recommended. Each bottle has 30ml with an average dose being 1ml. 1ml is 3/4 of the dropper or 25 mg. Each bottle contains 30+ days of use. Cycle Length: 8-12 weeks.
MK-2866 Ostarine Powder side effects
The side effects of Ostarine MK-2866 powder are limited as it appears to be a relatively side effect friendly drug. Many of the adverse effects associated with anabolic steroids will not exist with this SARM; however, some will, although mildly.
Estrogenic: The side effects of Ostarine should not include those of an estrogenic nature as the SARM CAS 1202044-20-9 does not aromatize.
Androgenic: Androgenic side effects of Ostarine, despite directly affecting the androgen receptor should not exist.
Cardiovascular: The side effects of Ostarine should present minimal cardiovascular risk. Both HDL and LDL levels may be reduced, but all data shows minimal to insignificant reductions.
Hepatotoxicity: Although orally administered, the side effects of Ostarine do not include liver toxicity. It does not mirror the MI metabolite associated with the SARM S4 that gives that particular SARM some hepatic activity.